CalciMedica is trading 10.89% up at $2.24, after rising from the September 8 close of $2.02, with no clear company-specific catalyst identified.
- The September 8 H.C. Wainwright announcement concerns a September 15 conference.
- Nasdaq compliance developments show the market-value issue was resolved, while the minimum-bid-price requirement remains outstanding through September 14.